TNF-α inhibitor etanercept improves cerebrovascular function in elderly RA patients: findings from a randomized controlled trial
This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Medical Ethics Committee of Xi'an Fifth Hospital (Ethics Approval No.: [2023] Ethics Review 55). The trial was also registered with the Chinese Clinical Trial Registry (Registration No.: ChiCTR2300077337; Date of Registration: 01/11/2023). Prior to participation, written informed consent was obtained from all individuals involved in the research.
Authors
- Hua Guo (ORCID: https://orcid.org/0000-0002-3345-8005)
- Xiaoqiang Huang (ORCID: https://orcid.org/0000-0001-9513-6610)
- Qiao Lin (ORCID: https://orcid.org/0000-0002-7017-8483)
- Rui‐song Wang
- Yuan Du (ORCID: https://orcid.org/0000-0002-3475-9213)
- Pei Chen (ORCID: https://orcid.org/0000-0002-2017-576X)
- Jun Yan (ORCID: https://orcid.org/0000-0002-7141-4687)
- Qiaoqiao Ren
Institutions
- Wuhan University (CN)
- Fifth Hospital In Wuhan (CN)
- First Hospital of Xi'an (CN)
Publication Details
- Journal
- BMC Rheumatology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1186/s41927-025-00589-6
- Primary Topic
- Neurological Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00